Active — Not RecruitingNot Applicable

Adapting the HOPE Online Support Intervention to Increase Uptake of Medications for Opioid Use Disorder

United States640 participantsStarted 2021-04-29

Plain-language summary

In a randomized controlled trial, with 3, 6-month and 1-year follow-up, this application aims to explore whether and how the HOPE intervention can be adapted to increase MOUD uptake among OUD patients, assess the effectiveness of using HOPE to increase MOUD requests, and analyze online community data to improve future intervention implementation and sustainability.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. ≥ 18 years of age;
✓. Resident of CA, NV, AZ, OR, WA;
✓. English speakers only;
✓. Has moderate to severe OUD;
✓. Is not currently prescribed MOUD;
✓. Reports using social media at least 2x per week;
✓. Has, or is willing to create a Facebook/social media account and accept a friend request and group invite from our study social media page

Exclusion criteria

✕. Anyone who does not fit inclusion criteria above
✕. Was a participant in phase I of the study
✕. Participants with active, unstable opioid, alcohol, sedative, or other substance use and/or unstable medical or psychiatric conditions as assessed by the study questionnaires will be reviewed by the study physician consultants and will be excluded and referred for acute care including detoxification, if needed.

What they're measuring

Number of requests to receive a resource on medications that can be used to treat opioid use disorder

Timeframe: request during the course of the 12-week community

Trial details

NCT IDNCT04712981

SponsorUniversity of California, Irvine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-07

View on ClinicalTrials.gov More Opioid Use Disorder trials